Apolipoprotein B (ApoB) is the primary structural protein found on all atherogenic lipoprotein particles — including LDL, VLDL, IDL, and Lp(a) — making it the most direct measure of cardiovascular risk from lipid burden. (source) Each of these particles carries exactly one ApoB molecule, so ApoB concentration directly counts the number of potentially artery-clogging particles in circulation.
For performance-focused individuals, elevated ApoB indicates that vascular function may be compromised — reducing oxygen delivery efficiency, increasing inflammation, and limiting recovery capacity. (source) ApoB is consistently shown to be a superior predictor of cardiovascular events compared to LDL-C, especially in metabolically active individuals where LDL particle number and size vary significantly from cholesterol content alone. (source)